KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases....

Pharmaceutical

KalVista Pharmaceuticals

KalVista Pharmaceuticals' headquarters in Chilworth, United Kingdom

T. Andrew Crockett

Bilal Arif

Rachel M. Morten

Nicole Sweeny

Brian Piekos

Brian Krex

Christopher M. Yea

Paul K. Audhya

Yoshihide O.

Sally van Kooten

Kerrie Cutting

Edward P. Feener

Nancy Stuart

Brian J. G. Pereira

Edward W. Unkart

Pat Treanor

The Directors Team at KalVista Pharmaceuticals comprises senior leaders responsible for guiding various specialized departments such as statistical programming, quality assurance, medicinal chemistry, preclinical pharmacology, program management, global health economics, biostatistics, early discovery chemistry, data management, HR, toxicology, CMC, medical communications, project management, drug product development, global marketing, API strategies, business development, and data strategy. This team collaborates to align departmental initiatives with the company's overarching goal of discovering, developing, and commercializing small molecule protease inhibitors for treating various diseases.

Directors Team

The Scientific Research Team at KalVista Pharmaceuticals is dedicated to the discovery and development of small molecule protease inhibitors. This collaborative group of research chemists, medicinal chemists, and scientists focuses on designing and synthesizing new compounds, conducting in vitro and in vivo studies, and advancing promising candidates through preclinical and clinical evaluation to address a range of diseases.

Scientific Research Team

The Clinical and Data Management team at KalVista Pharmaceuticals is responsible for overseeing clinical trials, ensuring regulatory compliance, managing clinical trial documentation, and handling data management processes. This includes the collection, analysis, and maintenance of clinical data to support the development and commercialization of small molecule protease inhibitors.

Clinical and Data Management

The Leadership Team at KalVista Pharmaceuticals is responsible for setting the strategic direction and overall vision of the company. This team, composed of key executives including the CEO, President, and Chief Scientific Officer, collaborates to oversee the development and commercialization of innovative protease inhibitors, ensuring alignment of scientific and operational goals while fostering a culture of innovation and accountability.

Leadership Team

The Regulatory Affairs Team at KalVista Pharmaceuticals is responsible for ensuring that the company's small molecule protease inhibitors meet all regulatory requirements. This includes preparing and submitting regulatory documents, maintaining compliance with international standards, and liaising with regulatory agencies to facilitate the approval of new drugs.

Regulatory Affairs Team

The Finance and Accounting team at KalVista Pharmaceuticals manages the company's financial health by overseeing budgeting, financial planning, and reporting. They ensure compliance with financial regulations, process accounts payable, and provide strategic financial insights to support the company's clinical-stage pharmaceutical initiatives.

KalVista Pharmaceuticals

Org chart

Board & advisors

Teams

Directors Team

Scientific Research Team

Clinical and Data Management

Leadership Team

Regulatory Affairs Team

Finance and Accounting

Offices

KalVista Pharmaceuticals

Org chart

Board & advisors

Teams

Directors Team

Scientific Research Team

Clinical and Data Management

Leadership Team

Regulatory Affairs Team

Finance and Accounting

Offices

Related companies